首页> Human vaccines & immunotherapeutics> A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model.

A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model.

导出 OA

翻译打印收藏纠错

第一作者： Hu,Liu

第一单位： State Key Laboratory for Agro-Biotechnology; College of Biological Science; China Agricultural University; Beijing, P.R. China.

作者： Hu,Liu ^[1] ; Shuang,Geng ^[2] ; Congcong,Feng ^[1] ; Xiaoping,Xie ^[1] ; Bing,Wu ^[1] ; Xuan,Chen ^[1] ; Qiang,Zou ^[1] ; Shuang,Wang ^[1] ; Jiantao,Cui ^[3] ; Rui,Xing ^[3] ; Wenmei,Li ^[3] ; Youyong,Lu ^[3] ; Bin,Wang ^[4]

作者单位： State Key Laboratory for Agro-Biotechnology; College of Biological Science; China Agricultural University; Beijing, P.R. China. ^[1] Key Laboratory of Medical Molecular Virology of MOH and MOE; Fudan University Shanghai Medical College; Shanghai, P.R. China. ^[2] Laboratory of Molecular Oncology; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education); Peking University Cancer Hospital & Institute; Beijing, P.R. China. ^[3] State Key Laboratory for Agro-Biotechnology; College of Biological Science; China Agricultural University; Beijing, P.R. China; Key Laboratory of Medical Molecular Virology of MOH and MOE; Fudan University Shanghai Medical College; Shanghai, P.R. China. ^[4]

关键词 B16F10 melanoma DNA vaccine cancer immunotherapy cytotoxic CD8+T cell p42.3